Abstract
Coligation of paired immunoglobulin-like receptor B (PIR-B) with B cell antigen receptor (BCR) blocks antigen-induced B cell activation. This inhibition is mediated in part by recruitment of SHP-1 and SHP-2 to the phosphorylated ITIMs in the cytoplasmic domain of PIR-B; however the molecular target(s) of these phosphatases remain elusive. Here we show that PIR-B ligation inhibits the BCR-induced tyrosine phosphorylation of Igα/Igβ, Syk, Btk and phospholipase C (PLC)-γ2. Overexpression of a catalytically inactive form of SHP-1 prevents the PIR-B-mediated inhibition of tyrosine phosphorylation of Syk, Btk, and PLC-γ2. Dephosphorylation of Syk and Btk mediated by SHP-1 leads to a decrease of their kinase activity, which in turn inhibits tyrosine phosphorylation of PLC-γ2. Furthermore, we define a requirement for Lyn in mediating tyrosine phosphorylation of PIR-B. Based on these results, we propose a model of PIR-B-mediated inhibitory signaling in which coligation of PIR-B and BCR results in phosphorylation of ITIMs by Lyn, subsequent recruitment of SHP-1, and a resulting inhibition of the BCR-induced inositol 1,4,5-trisphosphate generation by dephosphorylation of Syk and Btk.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Baba Y, Nonoyama S, Matsushita M, Yamadori T, Hashimoto S, Imai K, Arai S, Kunikata T, Kurimoto M, Kurosaki T, Ochs HD, Yata J, Kishimoto T and Tsukata S. . Blood in press.
Berridge MJ, Dawson RMC, Downes CP, Heslop JP and Irvine RF. . 1983 Biochem. J. 212: 473–482.
Binstadt BA, Brumbaugh KM, Dick CJ, Scharenberg AM, Williams BL, Colonna M, Lanier LL, Kinet J-P, Abraham RT and Leibson PJ. . 1996 Immunity 5: 629–638.
Bléry M, Kubagawa H, Chen C-C, Vély F, Cooper MD and Vivier E. . 1998 Proc. Natl. Acad. Sci. USA 95: 2446–2451.
Burkhardt AL, Brunswick M, Bolen JB and Mond JJ. . 1991 Proc. Natl. Acad. Sci. USA 88: 7410–7414.
Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet J-P and Long EO. . 1996 Immunity 4: 77–85.
Chan VWF, Meng F, Soriano P, DeFranco AL and Lowell CA. . 1997 Immunity 7: 69–81.
DeFranco AL. . 1997 Curr. Opin. Immunol. 9: 296–308.
Fluckiger A-C, Li Z, Kato RM, Wahl MI, Ochs HD, Longnecker R, Kinet J-P, Witte ON, Scharenberg AM and Rawlings DJ. . 1998 EMBO J. 17: 1973–1985.
Grynkiewicz G, Poenie M and Tsien RY. . 1985 J. Biol. Chem. 260: 3440–3450.
Gupta N, Scharenberg AM, Burshtyn DN, Wagtmann N, Lioubin MN, Rohrschneider LR, Kinet J-P and Long EO. . 1997 J. Exp. Med. 186: 473–478.
Hayami K, Fukuta D, Nishikawa Y, Yamashita Y, Inui M, Ohyama Y, Hikita M, Ohmori H and Takai T. . 1997 J. Biol. Chem. 272: 7320–7327.
Hippen KL, Buhl AM, D'Ambrosio D, Nakamura K, Persin C and Cambier JC. . 1997 Immunity 7: 49–58.
Kubagawa H, Burrows PD and Cooper MD. . 1997 Proc. Natl. Acad. Sci. USA 94: 5261–5266.
Kurosaki T. . 1997 Curr. Opin. Immunol. 9: 309–318.
Kurosaki T, Takata M, Yamanashi Y, Inazu T, Taniguchi T, Yamamoto T and Yamamura H. . 1994 J. Exp. Med. 179: 1725–1729.
Maeda A, Kurosaki M, Ono M, Takai T and Kurosaki T. . 1998 J. Exp. Med. 187: 1355–1360.
Nadler MJS, Chen B, Anderson JS, Wortis HH and Neel BG. . 1997 J. Biol. Chem. 272: 20038–20043.
Nishizumi H, Horikawa K, Mlinaric-Rascan I and Yamamoto T. . 1998 J. Exp. Med. 187: 1343–1348.
O'Rourke L, Tooze R and Fearon DT. . 1997 Curr. Opin. Immunol. 9: 324–329.
Ono M, Okada H, Bolland S, Yanagi S, Kurosaki T and Ravetch JV. . 1997 Cell 90: 293–301.
Pleiman CM, D'Ambrosio D and Cambier JC. . 1994 Immunol. Today 15: 393–399.
Putney Jr JW and Bird GSJ. . 1993 Cell 75: 199–201.
Reth M and Wienands J. . 1997 Annu. Rev. Immunol. 15: 453–479.
Sanchez M, Misulovin Z, Burkhardt AL, Mahajan S, Costa T, Franke R, Bolen JB and Nussenzweig M. . 1993 J. Exp. Med. 178: 1049–1055.
Saouaf SJ, Mahajan S, Rowley RB, Kut SA, Fargnoli J, Burkhardt AL, Tsukada S, Witte ON and Bolen JB. . 1994 Proc. Natl. Acad. Sci. USA 91: 9524–9528.
Scharenberg AM, El-Hillal O, Fruman DA, Beitz LO, Li Z, Lin S, Gout I, Cantley LC, Rawlings DJ and Kinet J-P. . 1998 EMBO J. 17: 1961–1972.
Sugawara H, Kurosaki M, Takata M and Kurosaki T. . 1997 EMBO J. 16: 3078–3088.
Takata M, Homma Y and Kurosaki T. . 1995 J. Exp. Med. 182: 907–914.
Takata M and Kurosaki T. . 1996 J. Exp. Med. 184: 31–40.
Takata M, Sabe H, Hata A, Inazu T, Homma Y, Nukada T, Yamamura H and Kurosaki T. . 1994 EMBO J. 13: 1341–1349.
Unkeless JC. . 1979 J. Exp. Med. 150: 580–596.
Wang J, Koizumi T and Watanabe T. . 1996 J. Exp. Med. 184: 831–838.
Yamanashi Y, Fukui Y, Wongsasant B, Kinoshita Y, Ichimori K, Toyoshima K and Yamamoto T. . 1992 Proc. Natl. Acad. Sci. USA 89: 1118–1122.
Acknowledgements
We would like to acknowledge M Kurosaki for the technical assistance, Dr H Umemori and Dr T Yamamoto for providing anti-Lyn Ab, and Dr S Arai (Fujisaki institute, Hayashibara Biochemical Laboratories Inc.) for generation of anti-Btk mAb 43-3B. This work was supported by grants to TK from the Ministry of Education, Science, Sports, and Culture of Japan, the Uehara Memorial Foundation, and the Sumitomo Foundation.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maeda, A., Scharenberg, A., Tsukada, S. et al. Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1. Oncogene 18, 2291–2297 (1999). https://doi.org/10.1038/sj.onc.1202552
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202552
Keywords
This article is cited by
-
Proteome analysis of CD5-positive diffuse large B cell lymphoma FFPE tissue reveals downregulation of DDX3X, DNAJB1, and B cell receptor signaling pathway proteins including BTK and Immunoglobulins
Clinical Proteomics (2023)
-
Reporter cell assay for human CD33 validated by specific antibodies and human iPSC-derived microglia
Scientific Reports (2021)
-
LILRB receptor-mediated regulation of myeloid cell maturation and function
Cancer Immunology, Immunotherapy (2017)
-
Functional requirements for inhibitory signal transmission by the immunomodulatory receptor CD300a
BMC Immunology (2012)
-
Phosphoproteomic analysis of Syk kinase signaling in human cancer cells reveals its role in cell–cell adhesion
Oncogene (2009)